MarketResearch.biz delivers in-depth insights on the global 3D bioprinting market in its upcoming report titled, “Global 3D Bioprinting Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global 3D bioprinting market is estimated to register a CAGR of XX.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global 3D bioprinting market is segmented on the basis of technology, application, and region.
Three dimensional printing of organs and biological tissues by layer-to-layer deposition of living cells in order to create functional organs and tissues is called 3D bioprinting. 3D bio-printers, bio-ink, and bioprocess protocols are used to create organic materials.
Rising organ transplantation procedures across the globe and increasing funding and investments by major manufacturers in 3d bioprinting technology are major factors driving growth of the global 3D bioprinting market. In addition, increasing adoption of 3D bioprinting technology for dental implants, tissue engineering, and drug discovery process is another factor driving growth of the global market. Increasing adoption of 3D bio-printers in food sector and in cosmetic industry is expected to further propel growth of the target market to a significant extent over the forecast period. In addition, use of 3D bioprinting technology could prevent cell rejection in case of organ transplantation, and could also replace humans and animals in lab testing procedures. This advantages of 3D bioprinting technology is expected to further fuel growth of the global market over the forecast
High cost of bioprinting devices and high treatment cost are major factors hampering growth of the global 3D bioprinting market. In addition, lack of skilled professionals and lack of awareness about 3D bioprinting technology in some developing and underdeveloped countries are other factors hampering growth of the global market.
North America market dominates the global 3D bioprinting market in terms of revenue and is expected to maintain its dominance over the forecast period. This growth can be attributed to rising investments in R&D of bioprinting technology by public and private players, early adoption of these technology owing to a well-developed healthcare system, and high disposable income of individuals in countries in this region. The Europe 3D bioprinting market accounts for second highest position in the global market and is expected to witness considerable growth over the next 10 years. The market in Asia Pacific is expected to witness significant growth in terms of revenue and is projected to register a CAGR of XX.X% over the next 10 years. This growth can be attributed to rapid development in healthcare infrastructure and rising adoption of advanced healthcare technology in in countries such as India, China, Japan, etc.
Global 3D bioprinting market Segmentation:
Segmentation on the basis of technology:
- Magnetic Levitation
- Inkjet Based
- Syringe Based
- Laser Based
Segmentation on the basis of application:
- Consumer/Personal Product Testing
- Food and Animal Product Bioprinting
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Organovo Holdings Inc.
- Cyfuse Biomedical K.K.
- EnvisionTEC GmbH
- Allevi Inc.
- Nano3D Biosciences Inc.
- 3Dynamic Systems Ltd.
- Aspect Biosystems Ltd.
- Regenovo Biotechnology Co. Ltd.
- TeVido BioDevices
- Bio3D Technologies
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!